- Home
- KTTA vs PRSO Comparison
KTTA vs PRSO Comparison
Compare KTTA & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- PRSO
- Stock Information
- Founded
- KTTA 2020
- PRSO 2008
- Country
- KTTA United States
- PRSO United States
- Employees
- KTTA N/A
- PRSO 42
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- KTTA Health Care
- PRSO Technology
- Exchange
- KTTA Nasdaq
- PRSO Nasdaq
- Market Cap
- KTTA 5.1M
- PRSO 5.4M
- IPO Year
- KTTA 2021
- PRSO 2001
- Fundamental
- Price
- KTTA $0.80
- PRSO $0.82
- Analyst Decision
- KTTA
- PRSO Strong Buy
- Analyst Count
- KTTA 0
- PRSO 1
- Target Price
- KTTA N/A
- PRSO $3.00
- AVG Volume (30 Days)
- KTTA 171.7K
- PRSO 84.3K
- Earning Date
- KTTA 08-14-2025
- PRSO 08-11-2025
- Dividend Yield
- KTTA N/A
- PRSO N/A
- EPS Growth
- KTTA N/A
- PRSO N/A
- EPS
- KTTA N/A
- PRSO N/A
- Revenue
- KTTA N/A
- PRSO $13,608,000.00
- Revenue This Year
- KTTA N/A
- PRSO N/A
- Revenue Next Year
- KTTA N/A
- PRSO $47.61
- P/E Ratio
- KTTA N/A
- PRSO N/A
- Revenue Growth
- KTTA N/A
- PRSO 1.80
- 52 Week Low
- KTTA $0.65
- PRSO $0.52
- 52 Week High
- KTTA $7.50
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- KTTA 55.44
- PRSO 40.50
- Support Level
- KTTA $0.75
- PRSO $0.77
- Resistance Level
- KTTA $0.91
- PRSO $0.93
- Average True Range (ATR)
- KTTA 0.06
- PRSO 0.05
- MACD
- KTTA 0.02
- PRSO 0.01
- Stochastic Oscillator
- KTTA 52.10
- PRSO 30.00
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.